JP2023540094A5 - - Google Patents
Info
- Publication number
- JP2023540094A5 JP2023540094A5 JP2023514415A JP2023514415A JP2023540094A5 JP 2023540094 A5 JP2023540094 A5 JP 2023540094A5 JP 2023514415 A JP2023514415 A JP 2023514415A JP 2023514415 A JP2023514415 A JP 2023514415A JP 2023540094 A5 JP2023540094 A5 JP 2023540094A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074361P | 2020-09-03 | 2020-09-03 | |
| US63/074,361 | 2020-09-03 | ||
| US202163179700P | 2021-04-26 | 2021-04-26 | |
| US63/179,700 | 2021-04-26 | ||
| PCT/US2021/048917 WO2022051537A1 (en) | 2020-09-03 | 2021-09-02 | Adeno-associated virus for delivery of kh902 (conbercept) and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023540094A JP2023540094A (ja) | 2023-09-21 |
| JPWO2022051537A5 JPWO2022051537A5 (https=) | 2024-09-06 |
| JP2023540094A5 true JP2023540094A5 (https=) | 2024-09-06 |
Family
ID=80491540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023514415A Pending JP2023540094A (ja) | 2020-09-03 | 2021-09-02 | Ｋｈ９０２（コンベルセプト）の送達のためのアデノ随伴ウイルスおよびその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230340529A1 (https=) |
| EP (1) | EP4208478A4 (https=) |
| JP (1) | JP2023540094A (https=) |
| KR (1) | KR20230061441A (https=) |
| AU (1) | AU2021336425A1 (https=) |
| BR (1) | BR112023003548A2 (https=) |
| CA (1) | CA3192736A1 (https=) |
| IL (1) | IL300864A (https=) |
| MX (1) | MX2023002695A (https=) |
| WO (1) | WO2022051537A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2020006435A (es) | 2017-12-19 | 2021-02-09 | Akouos Inc | Administracion de anticuerpos terapeuticos mediada por vector de virus adenoasociado (aav) en el oido interno. |
| IL303317A (en) | 2020-12-01 | 2023-07-01 | Akouos Inc | ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA |
| AU2024247959A1 (en) * | 2023-03-28 | 2025-10-09 | General Medicines Llc | Nucleic acid off-switches and methods and uses thereof |
| WO2024220389A2 (en) * | 2023-04-17 | 2024-10-24 | University Of Massachusetts | Aav2 variants and uses thereof |
| CN119656336A (zh) * | 2023-09-21 | 2025-03-21 | 成都弘基生物科技有限公司 | 一种重组腺相关病毒在制备治疗与血管新生相关眼病的药物中的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100897379B1 (ko) * | 2004-06-08 | 2009-05-14 | 쳉두 캉홍 바이오테크놀로지스 코. 리미티드 | 혈관신생-저해 키메릭 단백질 및 그 사용 |
| AU2014286996A1 (en) * | 2013-07-12 | 2016-01-07 | Iveric Bio, Inc. | Methods for treating or preventing ophthalmological conditions |
| EP3134522B1 (en) * | 2014-04-25 | 2021-10-06 | University of Massachusetts | Recombinant aav vectors useful for reducing immunity against transgene products |
| US11046955B2 (en) * | 2015-04-24 | 2021-06-29 | University Of Massachusetts | Modified AAV constructs and uses thereof |
| DK3471780T3 (da) * | 2016-06-16 | 2020-11-23 | Adverum Biotechnologies Inc | Behandling af amd med aav2-variant med aflibercept |
| AU2018227483A1 (en) * | 2017-02-28 | 2019-09-12 | Adverum Biotechnologies, Inc. | Modified AAV capsids and uses thereof |
| AU2018350990A1 (en) * | 2017-10-18 | 2020-05-21 | Regenxbio Inc. | Treatment of ocular diseases and metastatic colon cancer with human post-translationally modified VEGF-Trap |
| KR102205830B1 (ko) * | 2017-10-26 | 2021-01-21 | 주식회사 큐로진생명과학 | 솔루블 VEGFR-1 변이체 cDNA를 함유하는 rAAV를 포함하는 황반변성 치료용 조성물 |
| US11103552B2 (en) * | 2018-05-10 | 2021-08-31 | Regeneron Pharmaceuticals, Inc. | High concentration VEGF receptor fusion protein containing formulations |
-
2021
- 2021-09-02 BR BR112023003548A patent/BR112023003548A2/pt unknown
- 2021-09-02 MX MX2023002695A patent/MX2023002695A/es unknown
- 2021-09-02 CA CA3192736A patent/CA3192736A1/en active Pending
- 2021-09-02 WO PCT/US2021/048917 patent/WO2022051537A1/en not_active Ceased
- 2021-09-02 JP JP2023514415A patent/JP2023540094A/ja active Pending
- 2021-09-02 KR KR1020237010791A patent/KR20230061441A/ko active Pending
- 2021-09-02 AU AU2021336425A patent/AU2021336425A1/en active Pending
- 2021-09-02 EP EP21865133.9A patent/EP4208478A4/en active Pending
- 2021-09-02 IL IL300864A patent/IL300864A/en unknown
- 2021-09-02 US US18/024,359 patent/US20230340529A1/en active Pending